Phosphoinositide 3-kinase regulates membrane type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry

Cancer Research

Volumn 63, Issue 16, 2003, Pages 4757-4762

  Hess, Angela R ^a   Seftor, Elisabeth A ^a,b   Seftor, Richard E B ^a,b   Hendrix, Mary J C ^a,b,c  

^a Dept of Anatomy and Cell Biology ^*  (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; KALININ; LAMININ; LAMININ 5 GAMMA2; MATRIX METALLOPROTEINASE 14; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; BREAST TUMOR; CANCER CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME REGULATION; EPHA2 GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; MOLECULAR MECHANICS; MOLECULAR MIMICRY; OVARY CARCINOMA; PRIORITY JOURNAL; PROSTATE TUMOR; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UVEA MELANOMA; VASCULOGENIC MIMICRY; VE CADHERIN GENE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; HUMANS; LAMININ; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; MELANOMA; METALLOENDOPEPTIDASES; PROTEIN SUBUNITS; TUMOR CELLS, CULTURED;

EID: 0042941848     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Maniotis, A. J., Folberg, R., Hess, A., Seftor, E. A., Gardner, L. M., Pe'er, J., Trent, J. M., Meltzer, P. S., and Hendrix, M. J. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am. J. Pathol., 155: 739-752, 1999.
2. Kobayashi, H., Shirakawa, K., Kawamoto, S., Saga, T., Sato, N., Hiraga, A., Watanabe, I., Heike, Y., Togashi, K., Konishi, J., Brechbiel, M. W., and Wakasugi, H. Rapid accumulation and internalization of radiolabeled herceptin in an inflammatory breast cancer xenograft with vasculogenic mimicry predicted by the contrast-enhanced dynamic MRI with the macromolecular contrast agent G6-(1B4M-Gd)(256). Cancer Res., 62: 860-866, 2002.
3. Liu, C., Huang, H., Donate, F., Dickinson, C., Santucci, R., El Sheikh, A., Vessella, R., and Edgington, T. S. Prostate-specific membrane antigen directed selective thrombotic infarction of tumors. Cancer Res., 62: 5470-5475, 2002.
4. Sharma, N., Seftor, R. E., Seftor, E. A., Gruman, L. M., Heidger, P. M., Jr., Cohen, M. B., Lubaroff, D. M., and Hendrix, M. J. Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry. Prostate, 50: 189-201, 2002.
5. Shirakawa, K., Tsuda, H., Heike, Y., Kato, K., Asada, R., Inomata, M., Sasaki, H., Kasumi, F., Yoshimoto, M., Iwanaga, T., Konishi, F., Terada, M., and Wakasugi, H. Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancer. Cancer Res., 61: 445-451, 2001.
6. Shirakawa, K., Kobayashi, H., Heike, Y., Kawamoto, S., Brechbiel, M. W., Kasumi, F., Iwanaga, T., Konishi, F., Terada, M., and Wakasugi, H. Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft. Cancer Res., 62: 560-566, 2002.
7. Shirakawa, K., Wakasugi, H., Heike, Y., Watanabe, I., Yamada, S., Saito, K., and Konishi, F. Vasculogenic mimicry and pseudo-comedo formation in breast cancer. Int. J. Cancer, 99: 821-828, 2002.
8. Shirakawa, K., Furuhata, S., Watanabe, I., Hayase, H., Shimizu, A., Ikarashi, Y., Yoshida, T., Terada, M., Hashimoto, D., and Wakasugi, H. Induction of vasculogenesis in breast cancer models. Br. J. Cancer, 87: 1454-1461, 2002.
9. Sood, A. K., Seftor, E. A., Fletcher, M. S., Gardner, L. M., Heidger, P. M., Buller, R. E., Seftor, R. E., and Hendrix, M. J. Molecular determinants of ovarian cancer plasticity. Am. J. Pathol., 158: 1279-1288, 2001.
10. Sood, A. K., Fletcher, M. S., and Hendrix, M. J. C. The embryonic-like properties of aggressive human tumor cells. J. Soc. Gynecol. Investig., 9: 2-9, 2002.
11. Folkman, J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N. Engl. J. Med., 333: 1757-1763, 1995.
12. Kumar, R., and Fidler, I. J. Angiogenic molecules and cancer metastasis. In Vivo, 12: 27-34, 1998.
13. Rak, J., and Kerbel, R. S. Treating cancer by inhibiting angiogenesis: new hopes and potential pitfalls. Cancer Metastasis Rev., 15: 231-236, 1996.
14. Clarijs, R., Otte-Holler, I., Ruiter, D. J., and De Waal, R. M. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma. Investig. Ophthalmol. Vis. Sci., 43: 912-918, 2002.
15. Maniotis, A. J., Chen, X., Garcia, C., DeChristopher, P. J., Wu, D., Pe'er, J., and Folberg, R. Control of melanoma morphogenesis, endothelial survival, and perfusion by extracellular matrix. Lab. Investig., 82: 1031-1043, 2002.
16. Hendrix, M. J., Seftor, E. A., Meltzer, P. S., Gardner, L. M., Hess, A. R., Kirschmann, D. A., Schatteman, G. C., and Seftor, R. E. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc. Natl. Acad. Sci. USA, 98: 8018-8023, 2001.
17. Hess, A. R., Seftor, E. A., Gardner, L. M., Carles-Kinch, K., Schneider, G. B., Seftor, R. E., Kinch, M. S., and Hendrix, M. J. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2). Cancer Res., 61: 3250-3255, 2001.
18. Seftor, R. E., Seftor, E. A., Koshikawa, N., Meltzer, P. S., Gardner, L. M., Bilban, M., Stetler-Stevenson, W. G., Quaranta, V., and Hendrix, M. J. Cooperative interactions of laminin 5 γ2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res., 61: 6322-6327, 2001.
19. Kim, I., Moon, S. O., Park, S. K., Chae, S. W., and Koh, G. Y. Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ. Res., 89: 477-479, 2001.
20. Seftor, E. A., Meltzer, P. S., Kirschmann, D. A., Pe'er, J., Maniotis, A. J., Trent, J. M., Folberg, R., and Hendrix, M. J. Molecular determinants of human uveal melanoma invasion and metastasis. Clin. Exp. Metastasis, 19: 233-246, 2002.
21. Welch, D. R., Bisi, J. E., Miller, B. E., Conaway, D., Seftor, E. A., Yohem, K. H., Gilmore, L. B., Seftor, R. E., Nakajima, M., and Hendrix, M. J. Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line. Int. J. Cancer, 47: 227-237, 1991.
22. Hendrix, M. J., Seftor, E. A., Seftor, R. E., Kirschmann, D. A., Gardner, L. M., Boldt, H. C., Meyer, M., Pe'er, J., and Folberg, R. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF). Am. J. Pathol., 152: 855-863, 1998.
23. Quan, T., He, T., Kang, S., Voorhees, J. J., and Fisher, G. J. Connective tissue growth factor: expression in human skin in vivo and inhibition by ultraviolet irradiation. J. Investig. Dermatol., 118: 402-408. 2002.
24. Khwaja, A., Lehmann, K., Marte, B. M., and Downward, J. Phosphoinositide 3-kinase induces scattering and tubulogenesis in epithelial cells through a novel pathway. J. Biol. Chem., 273: 18793-18801, 1998.
25. Kovacs, E. M., Ali, R. G., McCormack, A. J., and Yap, A. S. E-cadherin homophilic ligation directly signals through Rac and phosphatidylinositol 3-kinase to regulate adhesive contacts. J. Biol. Chem., 277: 6708-6718, 2002.
26. Lafleur, M. A., Handsley, M. M., Knauper, V., Murphy, G., and Edwards, D. R. Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs). J. Cell Sci., 115: 3427-3438, 2002.
27. Nakahara, H., Howard, L., Thompson, E. W., Sato, H., Seiki, M., Yeh, Y., and Chen, W. T. Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc. Natl. Acad. Sci. USA, 94: 7959-7964, 1997.
28. Sounni, N. E., Baramova, E. N., Munaut, C., Maquoi, E., Frankenne, F., Foidart, J. M., and Noel, A. Expression of membrane type I matrix metalloproteinase (MTI-MMP) in A2058 melanoma cells is associated with MMP-2 activation and increased tumor growth and vascularization. Int. J. Cancer, 98: 23-28, 2002.
29. Giannelli, G., Falk-Marzillier, J., Schiraldi, O., Stetler-Stevenson, W. G., and Quaranta, V. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science (Wash. DC), 277: 225-228, 1997.
30. Koshikawa, N., Giannelli, G., Cirulli, V., Miyazaki, K., and Quaranta, V. Role of cell surface metalloprotease MTI-MMP in epithelial cell migration over laminin-5. J. Cell Biol., 148: 615-624, 2000.
31. Potgens, A. J., van Altena, M. C., Lubsen, N. H., Ruiter, D. J., and De Waal, R. M. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor. Am. J. Pathol., 148: 1203-1217, 1996.
32. Hendrix, M. J., Seftor, E. A., Hess, A. R., and Seftor, R. E. Angiogenesis: Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma. Nat. Rev. Cancer, 3: 411-421, 2003.
33. Sternlicht, M. D., and Werb, Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol., 17: 463-516, 2001.
34. Chang, C., and Werb, Z. The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends Cell Biol., 11: S37-S43, 2001.
35. Koike, T., Vernon, R. B., Hamner, M. A., Sadoun, E., and Reed, M. J. MTI-MMP, but not secreted MMPs, influences the migration of human microvascular endothelial cells in 3-dimensional collagen gels. J. Cell Biochem., 86: 748-758, 2002.
36. Haas, T. L., Davis, S. J., and Madri, J. A. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MTI-MMP and MMP-2 in microvascular endothelial cells. J. Biol. Chem., 273: 3604-3610, 1998.
37. Kubiatowski, T., Jang, T., Lachyankar, M. B., Salmonsen, R., Nabi. R. R., Quesenberry, P. J., Litofsky, N. S., Ross, A. H., and Recht, L. D. Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas. J. Neurosurg., 95: 480-488. 2001.
38. McLean, I. W. The biology of haematogenous metastasis in human uveal malignant melanoma. Virch. Arch. A Pathol. Anat. Histopathol., 422: 433-437, 1993.
39. Seftor, R. E. B., Seftor, E. A., Hess, A. R., Meltzer, P. S., and Hendrix. M. J. C. The role of the vasculogenic phenotype and its associated extracellular matrix in tumor progression: implications for immune surveillance. Clin. Appl. Immunol. Rev., 3: 263-276, 2003.
40. Bostick, P. J., Morton, D. L., Turner, R. R., Huynh, K. T., Wang, H. J., Elashoff, R., Essner, R., and Hoon, D. S. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J. Clin. Oncol., 17: 3238-3244, 1999.
41. Vanhaesebroeck, B., and Waterfield, M. D. Signaling by distinct classes of phosphoinositide 3-kinases, Exp. Cell Res., 253, 239-254, 1999.
42. Kim, D., Kim, S., Koh, H., Yoon, S. O., Chung, A. S., Cho, K. S., and Chung, J. Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production. FASEB J., 15: 1953-1962, 2001.
43. 2 activates pro-matrix metalloproteinase-2 through receptor tyrosine kinases/phosphatidylinositol 3-kinase/NF-κB pathway. J. Biol. Chem., 277: 30271-30282, 2002.
44. Zhang, D., and Brodt, P. Type I insulin-like growth factor regulates MTI-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling. Oncogene, 22: 974-982, 2003.